Axsome Therapeutics (AXSM) Misses Q1 EPS by 3c

Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• Axsome Therapeutics (AXSM) PT Raised to $316 at Mizuho
• Pyxis Oncology, Inc. (PYXS) Misses Q2 EPS by 4c
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance